Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the treatment of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://cormachhjt598985.collectblogs.com/83583624/semaglutide-a-potential-solution-for-metabolic-disorders